<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">ETM-0-0-10594</article-id>
<article-id pub-id-type="doi">10.3892/etm.2021.10594</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Long non-coding RNA <italic>HOTAIR</italic> knockdown alleviates lipopolysaccharide-induced acute respiratory distress syndrome and the associated inflammatory response by modulating the <italic>microRNA-30a-5p/PDE7A</italic> axis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Hongrong</given-names></name>
<xref rid="af1-etm-0-0-10594" ref-type="aff"/>
<xref rid="fn1-etm-0-0-10594" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Song</surname><given-names>Shasha</given-names></name>
<xref rid="af1-etm-0-0-10594" ref-type="aff"/>
<xref rid="fn1-etm-0-0-10594" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mu</surname><given-names>Xianyu</given-names></name>
<xref rid="af1-etm-0-0-10594" ref-type="aff"/>
<xref rid="c1-etm-0-0-10594" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-etm-0-0-10594">Department of Emergency, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-10594"><italic>Correspondence to:</italic> Dr Xianyu Mu, Department of Emergency, Yantai Yuhuangding Hospital, 20 Yuhuangding East Road, Zhifu, Yantai, Shandong 264000, P.R. China <email>muxianyu270@163.com</email></corresp>
<fn id="fn1-etm-0-0-10594"><p><sup>&#x002A;</sup>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>08</month>
<year>2021</year></pub-date>
<volume>22</volume>
<issue>4</issue>
<elocation-id>1160</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>08</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>05</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2020, Spandidos Publications</copyright-statement>
<copyright-year>2020</copyright-year>
</permissions>
<abstract>
<p>Acute respiratory distress syndrome (ARDS) is a severe pulmonary disease, which can be modulated by certain long non-coding (lnc)RNAs. The present study aimed to investigate the regulatory mechanism of lncRNA <italic>HOTAIR</italic> in ARDS and the inflammatory response induced by lipopolysaccharide (LPS). The mRNA expression levels of <italic>HOTAIR</italic>, <italic>microRNA (miR)-30a-5p</italic> and <italic>PDE7A</italic> were determined using reverse transcription-quantitative PCR, while a MTT assay was used to assess the viability of the MLE-12 cells and ELISA was used to determine the concentration of different inflammatory factors &#x005B;tumor necrosis factor (TNF)-&#x03B1;, IL-1&#x03B2; and IL-6&#x005D;. The interactions between <italic>miR-30a-5p</italic> and HOTAIR/PDE7A were predicted using TargetScan and StarBase databases and verified using a dual-luciferase reporter assay. The protein expression levels of PDE7A were determined using western blot analysis. Mouse models of LPS-induced ARDS were established to investigate the suppressive effect of <italic>HOTAIR</italic> knockdown on ARDS <italic>in vivo</italic>. lncRNA <italic>HOTAIR</italic> was increased in LPS-treated MLE-12 cells and in a ARDS mouse model. <italic>HOTAIR</italic> knockdown decreased the concentration of TNF-&#x03B1;, IL-1&#x03B2; and IL-6, and increased cell viability <italic>in vitro</italic>. <italic>miR-30a-5p</italic> upregulation decreased TNF-&#x03B1;, IL-1&#x03B2; and IL-6 concentrations, and increased cell viability <italic>in vitro</italic>. <italic>HOTAIR</italic> targeted <italic>miR-30a-5p</italic> and <italic>miR-30a-5p</italic> targeted <italic>PDE7A</italic>. <italic>miR-30a-5p</italic> downregulation and <italic>PDE7A</italic> upregulation reversed the suppressive effect of <italic>HOTAIR</italic> knockdown on the concentrations of TNF-&#x03B1;, IL-1&#x03B2; and IL-6, and the positive effect of <italic>HOTAIR</italic> knockdown on cell viability <italic>in vitro</italic>. HOTAIR knockdown also attenuated ARDS and the inflammatory response induced by LPS <italic>in vivo</italic>. The suppression of <italic>HOTAIR</italic> alleviated ARDS and the inflammatory response induced by LPS by modulating the <italic>miR-30a-5p</italic>/<italic>PDE7A</italic> axis. These results provide a potential therapeutic strategy for ARDS.</p>
</abstract>
<kwd-group>
<kwd>acute respiratory distress syndrome</kwd>
<kwd>inflammatory response</kwd>
<kwd>HOTAIR</kwd>
<kwd>miR-30a-5p</kwd>
<kwd>PDE7A</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> No funding was received.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Acute respiratory distress syndrome (ARDS) is the extreme manifestation of acute lung injury (ALI) (<xref rid="b1-etm-0-0-10594" ref-type="bibr">1</xref>). In 2016, estimates of the incidence of ARDS in high- and middle-income countries varied between 10.1 and 86.2 per 100,000 individuals per year in the general population (<xref rid="b2-etm-0-0-10594" ref-type="bibr">2</xref>). As a pulmonary disease that occurs in response to stimuli targeting the alveolar-capillary membrane, ALI/ARDS can lead to increased vascular permeability and subsequently, pulmonary oedema (<xref rid="b3-etm-0-0-10594" ref-type="bibr">3</xref>). Lipopolysaccharide (LPS) is considered to be a major active factor during the inflammatory response (<xref rid="b4-etm-0-0-10594" ref-type="bibr">4</xref>,<xref rid="b5-etm-0-0-10594" ref-type="bibr">5</xref>). LPS-induced inflammation has been reported to play a critical role in the pathogenesis of ALI (<xref rid="b6-etm-0-0-10594" ref-type="bibr">6</xref>). Consequently, further molecular research on the potential mechanisms of LPS-induced inflammatory factor release in ALI/ARDS and the development of new therapeutic targets for ARDS are urgently required.</p>
<p>There is increasing evidence that long non-coding (lnc) RNAs have been associated with regulating pulmonary diseases, including ALI/ARDS (<xref rid="b7-etm-0-0-10594 b8-etm-0-0-10594 b9-etm-0-0-10594" ref-type="bibr">7-9</xref>). Dai <italic>et al</italic> (<xref rid="b7-etm-0-0-10594" ref-type="bibr">7</xref>) showed that MALAT1 overexpression increased the concentration of LPS-induced inflammatory factors in mouse alveolar cells; therefore, accelerating the progression of LPS-induced ALI. Wang <italic>et al</italic> (<xref rid="b8-etm-0-0-10594" ref-type="bibr">8</xref>) revealed that THRIL mRNA expression level was positively correlated with IL-1&#x03B2; and TNF-&#x03B1; concentration in the tissues of patients with ARDS. Zhou <italic>et al</italic> (<xref rid="b9-etm-0-0-10594" ref-type="bibr">9</xref>) found that NEAT1 expression was markedly elevated in a mouse model of ALI and NEAT1 knockdown inhibited the release of inflammatory factors from mouse alveolar epithelial cells. Notably, <italic>HOTAIR</italic> has been associated with regulating the LPS-induced inflammatory response in different aspects, such as LPS-induced inflammatory injury in mouse chondrogenic cells (<xref rid="b10-etm-0-0-10594" ref-type="bibr">10</xref>), and in the LPS-induced inflammatory response in mice macrophages (<xref rid="b11-etm-0-0-10594" ref-type="bibr">11</xref>) and in cardiomyocytes from mice with sepsis (<xref rid="b12-etm-0-0-10594" ref-type="bibr">12</xref>). However, the detailed mechanism of <italic>HOTAIR</italic> in the LPS-induced inflammatory response in ALI/ARDS remains unknown.</p>
<p>It is widely known that microRNAs (miRNA/miR) have been associated with LPS-induced ALI and the release of inflammatory mediators (<xref rid="b13-etm-0-0-10594 b14-etm-0-0-10594 b15-etm-0-0-10594" ref-type="bibr">13-15</xref>). Li <italic>et al</italic> (<xref rid="b13-etm-0-0-10594" ref-type="bibr">13</xref>) revealed that the overexpression of <italic>miR-150</italic> decreased the concentration of IL-6, IL-1&#x03B2; and tumor necrosis factor (TNF)-&#x03B1; in mice with LPS-induced ALI. Cheng <italic>et al</italic> (<xref rid="b14-etm-0-0-10594" ref-type="bibr">14</xref>) demonstrated that <italic>miR-424</italic> upregulation inhibited the release of inflammatory factors from LPS-induced alveolar epithelial cells. He <italic>et al</italic> (<xref rid="b15-etm-0-0-10594" ref-type="bibr">15</xref>) found that lung injury and the inflammatory response induced by LPS were attenuated by <italic>miR-146b</italic> overexpression; therefore, ameliorating LPS-induced ALI. Notably, <italic>miR-30a-5p</italic> has been shown to have a protective role in LPS-induced ALI in children (<xref rid="b16-etm-0-0-10594" ref-type="bibr">16</xref>). In addition, lncRNAs can act as competing endogenous RNAs or sponges of miRNAs. <italic>HOTAIR</italic> has been reported to regulate numerous miRNAs in several types of cancer, such as <italic>miR-138-5p</italic> in ovarian cancer (<xref rid="b17-etm-0-0-10594" ref-type="bibr">17</xref>), <italic>miR-1277-5p</italic> in gastric cancer (<xref rid="b18-etm-0-0-10594" ref-type="bibr">18</xref>), <italic>miR-449b-5p</italic> (<xref rid="b19-etm-0-0-10594" ref-type="bibr">19</xref>) or <italic>miR-601</italic> (<xref rid="b20-etm-0-0-10594" ref-type="bibr">20</xref>) in breast cancer and <italic>miR-203</italic> in lung cancer (<xref rid="b21-etm-0-0-10594" ref-type="bibr">21</xref>). However, the mechanisms whereby lncRNA <italic>HOTAIR</italic> regulates <italic>miR-30a-5p</italic> in ARDS/ALI have not yet been reported.</p>
<p>In the present study the effects of lncRNA <italic>HOTAIR</italic> knockdown on the concentrations of inflammatory factors in MLE-12 cells, the regulatory mechanism of how <italic>HOTAIR</italic> regulates the <italic>miR-30a-5p</italic>/<italic>PDE7A</italic> axis in LPS-induced MLE-12 cells and the effect of <italic>HOTAIR</italic> knockdown on LPS-induced ARDS <italic>in vivo</italic> were investigated. The results are aimed to provide a promising therapeutic target for ARDS.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell culture, grouping and transfection</title>
<p>The murine alveolar epithelial cell line, MLE-12, was purchased from Baiye Biotech, Ltd. The MLE-12 cells were cultured at 37&#x02DA;C in a humidified incubator with 5&#x0025; CO<sub>2</sub>, in DMEM (Invitrogen; Thermo Fisher Scientific, Inc.), supplemented with 10&#x0025; fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) and 0.1&#x0025; penicillin/streptomycin.</p>
<p>A short hairpin (sh)RNA-non-targeting negative control (sh-NC) and shRNA targeting <italic>HOTAIR</italic> (sh-<italic>HOTAIR</italic>) were purchased from Sangon Biotech, Co., Ltd. A PDE7A-overexpression plasmid (pcDNA-PDE7A) and its NC (pcDNA-NC), <italic>miR-30a-5p</italic> mimics/miR-NC and <italic>miR-30a-5p</italic> inhibitor/inhibitor NC were all purchased from Guangzhou RiboBio Co., Ltd. The aforementioned molecules (all at 20 nM) were transfected into the MLE-12 cells using Lipofectamine<sup>&#x00AE;</sup> 3000 (Invitrogen; Thermo Fisher Scientific, Inc.) at 37&#x02DA;C for 48 h. Subsequently, the transfected cells were induced with LPS (1 &#x00B5;g/ml; Sigma-Aldrich; Merck KGaA). MLE-12 cells without any treatments were served as the controls. The next day, the MLE-12 cells were harvested for the following experiments.</p>
</sec>
<sec>
<title>Reverse transcription-quantitative PCR (RT-qPCR)</title>
<p>Total RNA was extracted from the mouse cells or lung tissues using TRIzol<sup>&#x00AE;</sup> (Invitrogen; Thermo Fisher Scientific, Inc.). Total RNA (500 ng) was reverse transcribed into cDNA at 42&#x02DA;C for 45 min using a First-Strand cDNA Synthesis kit (APeXBIO Technology LLC) and qPCR was performed with SYBR Green FAST MasterMix kit (Qiagen GmbH), according to the manufacturer&#x0027;s instructions. The following thermocycling conditions were used for qPCR: Initial denaturation at 94&#x02DA;C for 10 min, followed by 40 cycles at 94&#x02DA;C for 10 sec, 60&#x02DA;C for 20 sec and 72&#x02DA;C for 1 min. <italic>GADPH</italic> and <italic>U6</italic> were used as the internal references. The respective sequences of primers were as follows: HOTAIR forward, 5&#x0027;-GGTAGAAAAAGCAACCACGAAGC-3&#x0027; and reverse, 5&#x0027;-ACATAAACCTCTGTCTGTGAGTGCC-3&#x0027;; miR-30a-5p forward, 5&#x0027;-AACGAGACGACGACAGAC-3&#x0027; and reverse, 5&#x0027;-TGTAAACATCCTCGACTGGAAG-3&#x0027;; PDE7A forward, 5&#x0027;-GGAAATAGTCTAGTAAGCTTAACC-3&#x0027; and reverse, 5&#x0027;-GGCAGATGTGAGAATAAGCCTG-3&#x0027;; GAPDH forward, 5&#x0027;-TCCGCCCCTTCCGCTGATG-3&#x0027; and reverse, 5&#x0027;-CACGGAAGGCCATGCCAGTGA-3&#x0027;; U6 forward, 5&#x0027;-CTCGCTTCGGCAGCACA-3&#x0027; and reverse 5&#x0027;-AACGCTTCAGAATTTGCGT-3&#x0027;. Gene expression was quantified using the 2<sup>-&#x0394;&#x0394;Cq</sup> method (<xref rid="b22-etm-0-0-10594" ref-type="bibr">22</xref>).</p>
</sec>
<sec>
<title>MTT assay</title>
<p>The viability of the MLE-12 cells was determined using a MTT assay. Transfected and LPS-treated MLE-12 cells were seeded into a 96-well plate, at 2x10<sup>5</sup> cells per well and incubated at 37&#x02DA;C. After incubation for 24 h, 20 &#x00B5;l MTT (Shanghai GeneChem, Co., Ltd.) was added to each well. After incubation for 2 h at 37&#x02DA;C, cell viability (optical density at 570 nm) was analyzed using a Multiskan Spectrum microplate reader (Thermo Fisher Scientific, Inc.).</p>
</sec>
<sec>
<title>ELISA</title>
<p>The concentration of the inflammatory factors &#x005B;TNF-&#x03B1; (cat. no. 70-EK182HS-96), IL-1&#x03B2; (cat. no. 70-EK101BHS-96) and IL-6 (cat. no. 70-EK106/2-24)&#x005D; in the MLE-12 cells or mouse bronchoalveolar lavage fluid (BALF) were measured using specific ELISA kits (Multisciences Biotech Co., Ltd.), according to the manufacturer&#x0027;s protocol. A Multiskan Spectrum microplate reader (Thermo Fisher Scientific, Inc.) was used to determine the absorbance at 450 nm.</p>
</sec>
<sec>
<title>Target prediction</title>
<p>The miRNA targets of <italic>HOTAIR</italic> were predicted using StarBase database (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://starbase.sysu.edu.cn/">http://starbase.sysu.edu.cn/</ext-link>). In addition, the mRNA targets of <italic>miR-30a-5p</italic> were predicted using TargetScan database (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.targetscan.org">http://www.targetscan.org</ext-link>).</p>
</sec>
<sec>
<title>Dual luciferase reporter (DLR) assay</title>
<p>The 3&#x0027;-untranslated region sequences containing the <italic>HOTAIR</italic> binding site were cloned into the pGL3 vector (Promega Corporation) to establish the wild-type (WT) vector. The Phusion Site-Directed Mutagenesis kit (Thermo Fisher Scientific, Inc.) was used to construct the mutant vector. The WT or mutant vectors and the <italic>miR-146a</italic> mimics or miR-NC were co-transfected into the MLE-12 cells using Lipofectamine 3000 (Invitrogen; Thermo Fisher Scientific, Inc.) at 37&#x02DA;C for 48 h. A DLR Assay System (Promega Corporation) was used to determine relative luciferase activity. The activity of firefly luciferase was normalized to the activity of <italic>Renilla</italic> luciferase.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>RIPA buffer (Beyotime Institute of Biotechnology), containing protease inhibitors was used to extract total protein from the MLE-12 cells. Protein concentration was then determined using a BCA Protein Assay kit (Abcam). A total of 50 &#x00B5;g protein/lane was separated using 10&#x0025; SDS-PAGE and the resolved proteins were transferred onto PVDF membranes. The membranes were blocked with 5&#x0025; bovine serum albumin (Thermo Fisher Scientific, Inc.) for 2 h at room temperature. Following which, the membranes were incubated overnight at 4&#x02DA;C with the primary antibodies against PDE7A (1:1,000; cat. no. ab14616; Abcam) and tubulin (1:1,000; cat. no. ab6160; Abcam). Subsequently, the membranes were washed 3 times with TBS-Tween-20 (0.05&#x0025;), then incubated with an HRP-conjugated anti-rabbit IgG secondary antibody (1:5,000; cat. no. ab6721; Abcam) and an HRP-conjugated anti-rat IgG secondary antibody (1:5,000; cat. no ab6734; Abcam), respectively, at room temperature for 1 h. Tubulin was used as the internal reference. An enhanced chemiluminescence detection kit (Thermo Fisher Scientific, Inc.) was used to detect the bands, which were then quantified using Gel-Pro Analyzer software (v4.0; Media Cybernetics, Inc.).</p>
</sec>
<sec>
<title>Construction of an ARDS mouse model</title>
<p>A total of 20 female BALB/c nude mice (4-5 weeks; weighing 20&#x00B1;2 g) were purchased from Cavens Lab. All mice were housed under controlled conditions (25&#x02DA;C; 50&#x0025; humidity; 12 h light/dark cycle) and had free access to food and water. The mouse model of ARDS was constructed by intratracheal instillation of 2 mg/kg LPS. The mice were randomly divided into sham, ARDS, ARDS + sh-NC and ARDS + sh-<italic>HOTAIR</italic> groups (n=5). After LPS treatment for 48 h, the mice in the ARDS + sh-<italic>HOTAIR</italic> group were treated with sh-<italic>HOTAIR</italic> lentivirus (2x10<sup>7</sup> transducing units/ml by intravenous injection), while those in the ARDS + sh-NC group were intravenously injected with an equal quantity of sh-NC lentivirus. Simultaneously, the mice in the sham group were intravenously injected with an equal volume of saline. The next day, the mice were anesthetized with sodium pentobarbital (50 mg/kg) and euthanized via cervical dislocation. Subsequently, the BALF samples were collected and centrifuged, and the resulting supernatants were used to measure the concentration of TNF-&#x03B1;, IL-6 and IL-1&#x03B2;.</p>
</sec>
<sec>
<title>Histopathological examination using H&#x0026;E staining</title>
<p>Fresh mouse lung samples were resected, then fixed with 4&#x0025; paraformaldehyde at 37&#x02DA;C for 1 day. The samples were then embedded in paraffin and cut into 6-&#x00B5;m thick sections. The sections were immediately stained with H&#x0026;E for 15 min at room temperature, then observed using a light microscope (magnification, x200). The injury score was calculated based on a previous study (<xref rid="b23-etm-0-0-10594" ref-type="bibr">23</xref>).</p>
</sec>
<sec>
<title>Lung function assay</title>
<p>After sacrifice of the mice, arterial blood samples (5 ml) were collected from mouse carotid arteries. An automatic blood gas analyzer (Radiometer Medical ApS) was used to determine the partial pressure of oxygen (PaO<sub>2</sub>) and carbon dioxide (PaCO<sub>2</sub>). The wet weight of the fresh lung tissues was then determined. The tissues were dried at 60&#x02DA;C for 72 h and the dry weight was then determined. The wet/dry weight ratio of the lung samples was used as a measure of tissue oedema.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>SPSS software (v20.0; IBM, Corp.) was used to perform statistical analyses. The data are presented as the mean &#x00B1; standard deviation. A Student&#x0027;s t-test (unpaired) was used to assess the differences between two groups, while one-way ANOVA was used to evaluate the differences among multiple groups, followed by a Tukey&#x0027;s multiple comparisons test. P&#x003C;0.05 was considered to indicate a statistically significant difference. All experiments were performed in independently 3 times in triplicate.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>lncRNA HOTAIR knockdown decreases the concentration of the inflammatory factors in LPS-induced MLE-12 cells</title>
<p><italic>HOTAIR</italic> mRNA expression level was upregulated in the MLE-12 cells in the LPS group compared with that in the control group (P&#x003C;0.01; <xref rid="f1-etm-0-0-10594" ref-type="fig">Fig. 1A</xref>). RT-qPCR was then used to determine the transfection efficiency of sh-<italic>HOTAIR</italic> and sh-NC in the MLE-12 cells and the results illustrated that HOTAIR expression was significantly decreased in the sh-<italic>HOTAIR</italic> group compared with that in the sh-NC group (P&#x003C;0.01; <xref rid="f1-etm-0-0-10594" ref-type="fig">Fig. 1B</xref>). A MTT assay revealed that, compared with that in the control cells, treatment with LPS significantly decreased cell viability. Cell viability in the sh-HOTAIR + LPS group was also significantly increased compared with that in the sh-NC + LPS group (P&#x003C;0.01; <xref rid="f1-etm-0-0-10594" ref-type="fig">Fig. 1C</xref>). ELISA results showed that the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1; were all upregulated in the MLE-12 cells in the LPS group compared with that in the control group. However, transfection with sh-<italic>HOTAIR</italic> significantly decreased the concentration of the inflammatory factors in the MLE-12 cells treated with LPS compared with that in cells transfected with sh-NC (P&#x003C;0.01; <xref rid="f1-etm-0-0-10594" ref-type="fig">Fig. 1D-F</xref>).</p>
</sec>
<sec>
<title>lncRNA HOTAIR targets miR-30a-5p</title>
<p>The potential binding sites between <italic>HOTAIR</italic> and <italic>miR-30a-5p</italic> were predicted using StarBase database (<xref rid="f2-etm-0-0-10594" ref-type="fig">Fig. 2A</xref>). Among the 46 miRNA targets predicted, miR-30a-5p was selected for further analysis as it has been associated with ALI (<xref rid="b16-etm-0-0-10594" ref-type="bibr">16</xref>) and its unknown regulatory association with HOTAIR. The mRNA expression levels of <italic>miR-30a-5p</italic> following transfection of the MLE-12 cells with sh-<italic>HOTAIR</italic> or sh-NC were also determined. The results showed that <italic>miR-30a-5p</italic> expression level was increased in the sh-<italic>HOTAIR</italic> group compared with that in the sh-NC group (P&#x003C;0.01; <xref rid="f2-etm-0-0-10594" ref-type="fig">Fig. 2B</xref>). Subsequently, a DLR assay was performed to further verify the interaction between <italic>HOTAIR</italic> and <italic>miR-30a-5p</italic>. The results showed that luciferase activity was lower in the <italic>HOTAIR</italic> WT + <italic>miR-30a-5p</italic> mimics group compared with that in the <italic>HOTAIR</italic> WT + miR-NC group (P&#x003C;0.01; <xref rid="f2-etm-0-0-10594" ref-type="fig">Fig. 2C</xref>).</p>
</sec>
<sec>
<title>Overexpression of miR-30a-5p decreases the concentration of the inflammatory factors in the LPS-induced MLE-12 cells</title>
<p>The mRNA expression level of <italic>miR-30a-5p</italic> was significantly lower in the LPS group compared with that in the control group (P&#x003C;0.01; <xref rid="f3-etm-0-0-10594" ref-type="fig">Fig. 3A</xref>). The transfection efficiency of the <italic>miR-30a-50p</italic> mimics, inhibitor and their respective NCs in the MLE-12 cells was determined using RT-qPCR. The results revealed that <italic>miR-30a-5p</italic> mRNA expression levels were downregulated by the <italic>miR-30a-5p</italic> inhibitor and upregulated by <italic>miR-30a-5p</italic> mimics (P&#x003C;0.01; <xref rid="f3-etm-0-0-10594" ref-type="fig">Fig. 3B</xref>). After treatment with LPS, the results from a MTT assay and ELISA demonstrated that compared with that in the miR-NC group, cell viability and the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1; was increased and decreased, respectively, in the <italic>miR-30a-5p</italic> mimics group (P&#x003C;0.01; <xref rid="f3-etm-0-0-10594" ref-type="fig">Fig. 3C-F</xref>).</p>
</sec>
<sec>
<title>miR-30a-5p targets PDE7A</title>
<p>Using TargetScan database, the potential binding site between <italic>miR-30a-5p</italic> and <italic>PDE7A</italic> was predicted (<xref rid="f4-etm-0-0-10594" ref-type="fig">Fig. 4A</xref>). A total of 1,570 targets were predicted. PDE7A was selected for further analysis as it has been associated with pulmonary inflammatory diseases, such as chronic obstructive pulmonary disease and asthma (<xref rid="b24-etm-0-0-10594" ref-type="bibr">24</xref>). Western blot analysis showed that the protein expression levels of PDE7A were decreased in the <italic>miR-30a-5p</italic> mimics group compared with that in the miR-NC group (P&#x003C;0.01; <xref rid="f4-etm-0-0-10594" ref-type="fig">Fig. 4B</xref>). DLR assays showed that luciferase activity was lower in the <italic>PDE7A</italic> WT + <italic>miR-30a-5p</italic> mimics group compared with that in the <italic>PDE7A</italic> WT + miR-NC group (P&#x003C;0.01; <xref rid="f4-etm-0-0-10594" ref-type="fig">Fig. 4C</xref>).</p>
</sec>
<sec>
<title>lncRNA HOTAIR knockdown decreases inflammatory factor concentration in LPS-induced MLE-12 cells by regulating the miR-30a-5p/PDE7A axis</title>
<p>Western blot analysis was used to determine the protein expression levels of PDE7A in LPS-induced MLE-12 cells. The results showed that LPS treatment significantly increased PDE7A protein expression levels (P&#x003C;0.01; <xref rid="f5-etm-0-0-10594" ref-type="fig">Fig. 5A</xref>). pcDNA-PDE7A or pcDNA-NC were then transfected into the MLE-12 cells and the results from western blot analysis demonstrated that PDE7A overexpression significantly increased the protein expression levels of PDE7A (P&#x003C;0.01; <xref rid="f5-etm-0-0-10594" ref-type="fig">Fig. 5B</xref>). Subsequently, sh-NC, sh-<italic>HOTAIR</italic>, or sh-<italic>HOTAIR</italic> + <italic>miR-30a-5p</italic> inhibitor was transfected into the MLE-12 cells, then stimulated with LPS. The protein expression level of PDE7A was subsequently analyzed and the results indicated that <italic>HOTAIR</italic> knockdown decreased the protein expression level of PDE7A, whereas downregulation of <italic>miR-30-5p</italic> reversed the inhibitory effect of <italic>HOTAIR</italic> knockdown on PDE7A protein expression levels (P&#x003C;0.01; <xref rid="f5-etm-0-0-10594" ref-type="fig">Fig. 5C</xref>). The results from the MTT assay showed that cell viability increased in the sh-<italic>HOTAIR</italic> group compared with that in the sh-NC group, whereas cell viability in both the sh-<italic>HOTAIR</italic> + <italic>miR-30a-5p</italic> inhibitor group and the sh <italic>HOTAIR</italic> + pcDNA-PDE7A group was partly reduced compared with that in the sh-<italic>HOTAIR</italic> group (P&#x003C;0.01; <xref rid="f5-etm-0-0-10594" ref-type="fig">Fig. 5D</xref>). ELISA results showed that the concentrations of IL-6, IL-1&#x03B2;, and TNF-&#x03B1; were all decreased by <italic>HOTAIR</italic> knockdown. However, downregulation of <italic>miR-30a-5p</italic> and upregulation of PDE7A both reversed the suppressive effect of <italic>HOTAIR</italic> knockdown on the concentration of the inflammatory factors (P&#x003C;0.01; <xref rid="f5-etm-0-0-10594" ref-type="fig">Fig. 5E-G</xref>).</p>
</sec>
<sec>
<title>lncRNA HOTAIR knockdown attenuates LPS-induced ARDS and the ARDS-related inflammatory response in vivo</title>
<p>The mRNA expression levels of <italic>HOTAIR</italic>, <italic>miR-30a-5p</italic>, and <italic>PDE7A</italic> in mouse lung tissues were determined using RT-qPCR. The results showed that, compared with that in the sham group, <italic>HOTAIR</italic> and <italic>PDE7A</italic> mRNA expression levels were elevated in the ARDS group, whereas <italic>miR-30a-5p</italic> mRNA expression levels were lower in the ARDS group (P&#x003C;0.05; <xref rid="f6-etm-0-0-10594" ref-type="fig">Fig. 6A-C</xref>). Following an intravenous injection with sh-<italic>HOTAIR</italic> or sh-NC lentiviruses, the mRNA expression levels of <italic>HOTAIR</italic> and <italic>PDE7A</italic> were downregulated in the lung tissues of mice in the ARDS + sh-<italic>HOTAIR</italic> group compared with that in the ARDS group. However, <italic>miR-30a-5p</italic> mRNA expression levels were upregulated in the ARDS + sh-<italic>HOTAIR</italic> group compared with that in the ARDS group. As shown in <xref rid="f6-etm-0-0-10594" ref-type="fig">Fig. 6D</xref>, the histopathological changes and injury scores of lung tissues were analyzed using H&#x0026;E staining. Inflammatory cell infiltration and interstitial oedema were more severe in the ARDS group compared with that in the sham group. <italic>HOTAIR</italic> knockdown markedly ameliorated these effects. The injury scores were higher in the ARDS group compared with that in the sham group. <italic>HOTAIR</italic> knockdown significantly decreased the injury scores of the lung tissues (P&#x003C;0.01; <xref rid="f6-etm-0-0-10594" ref-type="fig">Fig. 6D</xref>). Lung function assays demonstrated that, compared with that in the sham group, PaCO<sub>2</sub> levels and the lung wet/dry weight ratios were increased, whereas PaO<sub>2</sub> levels were decreased in the ARDS group (P&#x003C;0.01; <xref rid="f6-etm-0-0-10594" ref-type="fig">Fig. 6E-G</xref>). <italic>HOTAIR</italic> knockdown decreased PaCO<sub>2</sub> levels and lung wet/dry weight ratios, and increased PaO<sub>2</sub> levels. ELISA results showed that IL-6, IL-1&#x03B2; and TNF-&#x03B1; concentration in the mouse BALF samples were all elevated in the ARDS group compared with that in the sham group (P&#x003C;0.01; <xref rid="f6-etm-0-0-10594" ref-type="fig">Fig. 6H-J</xref>). However, <italic>HOTAIR</italic> knockdown significantly reversed the promoting effect of ARDS on inflammatory factor levels.</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>As a severe form of ALI, the cost to treat ARDS is high, which severely affects the health and quality of life in patients with ARDS (<xref rid="b25-etm-0-0-10594" ref-type="bibr">25</xref>). Several lncRNAs have been associated with the progression of ALI and ARDS (<xref rid="b7-etm-0-0-10594 b8-etm-0-0-10594 b9-etm-0-0-10594" ref-type="bibr">7-9</xref>). Dai <italic>et al</italic> (<xref rid="b7-etm-0-0-10594" ref-type="bibr">7</xref>) found high protein expression levels of MALAT1 in the lung tissues from an LPS-induced rat ALI model. Wang <italic>et al</italic> (<xref rid="b8-etm-0-0-10594" ref-type="bibr">8</xref>) showed that THRIL expression was upregulated in lung tissues from patients with ARDS. Zhou <italic>et al</italic> (<xref rid="b9-etm-0-0-10594" ref-type="bibr">9</xref>) demonstrated that NEAT1 was highly expressed in the lung tissues of mice with LPS-induced ALI and in LPS-treated mouse alveolar epithelial cells. Consistent with the aforementioned results, the present study showed that <italic>HOTAIR</italic> mRNA expression levels were increased in the lung tissues from mice with LPS-induced ARDS and in LPS-treated MLE-12 cells. Therefore, the results from the present study suggested that <italic>HOTAIR</italic> may act as a pathogenic factor in ARDS.</p>
<p>Previous studies have reported that lncRNAs act as crucial regulators in hypoxic lung diseases and inflammatory epithelial injury (<xref rid="b26-etm-0-0-10594" ref-type="bibr">26</xref>,<xref rid="b27-etm-0-0-10594" ref-type="bibr">27</xref>), by affecting processes, such as inflammation and interstitial oedema (<xref rid="b7-etm-0-0-10594" ref-type="bibr">7</xref>,<xref rid="b28-etm-0-0-10594" ref-type="bibr">28</xref>,<xref rid="b29-etm-0-0-10594" ref-type="bibr">29</xref>). Dai <italic>et al</italic> (<xref rid="b7-etm-0-0-10594" ref-type="bibr">7</xref>) have shown that MALAT1 inhibition led to a marked decrease in the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1; in rat lung tissues. In addition, histopathological examination showed that MALAT1 inhibition distinctly attenuated lung tissue injury. Jiang <italic>et al</italic> (<xref rid="b29-etm-0-0-10594" ref-type="bibr">29</xref>) showed that the PaO<sub>2</sub>/FiO<sub>2</sub> ratio was decreased and the lung wet/dry weight ratio was increased in ARDS. Kcnq1ot1 knockdown in mice was shown to reverse the suppressive effect of LPS on the PaO<sub>2</sub>/FiO<sub>2</sub> ratio and the positive effect of LPS on the lung wet/dry weight ratio (<xref rid="b29-etm-0-0-10594" ref-type="bibr">29</xref>). Consistent with the aforementioned results, in the present study, it was found that injury scores, lung wet/dry weight ratios, PaCO<sub>2</sub> levels and the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1; were increased, and PaO<sub>2</sub> levels were decreased in a mouse model of ARDS. <italic>HOTAIR</italic> knockdown using a sh <italic>HOTAIR</italic> lentivirus injection reversed the positive effect of LPS on injury scores, lung wet/dry weight ratios, PaCO<sub>2</sub> levels, and the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1;, and the negative effect of LPS on PaO<sub>2</sub> levels. These results suggested that <italic>HOTAIR</italic> knockdown attenuated the LPS-induced inflammatory response and LPS-induced ALI. To further verify this hypothesis, further experiments were performed using the MLE-12 cells and it was found that sh-<italic>HOTAIR</italic> reversed the negative effect of LPS on cell viability and the positive effect of LPS on the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1;. The results from the present study are consistent with those of other studies (<xref rid="b10-etm-0-0-10594 b11-etm-0-0-10594 b12-etm-0-0-10594" ref-type="bibr">10-12</xref>), suggesting that <italic>HOTAIR</italic> knockdown attenuated the LPS-induced inflammatory response and LPS-induced ALI <italic>in vivo</italic> and <italic>in vitro</italic>.</p>
<p>Increasing evidence has indicated that miRNA expression levels were downregulated in LPS-induced rat models of ALI or LPS-treated cells. For example, <italic>miR-497a-5p</italic> (<xref rid="b30-etm-0-0-10594" ref-type="bibr">30</xref>) and <italic>miR-381-3p</italic> (<xref rid="b29-etm-0-0-10594" ref-type="bibr">29</xref>) expression levels were downregulated in an LPS-induced mouse model of ALI, while <italic>miR-424</italic> (<xref rid="b14-etm-0-0-10594" ref-type="bibr">14</xref>) expression levels were downregulated in alveolar epithelial cells, and <italic>miR-146b</italic> (<xref rid="b15-etm-0-0-10594" ref-type="bibr">15</xref>) expression levels were downregulated in murine lung alveolar macrophages. Similarly, in the present study it was found that <italic>miR-30a-5p</italic> expression levels were downregulated in both an LPS-induced mouse model of ARDS and in LPS-treated MLE-12 cells. In addition, previous studies have shown that miRNAs have a role in modulating pulmonary inflammation (<xref rid="b13-etm-0-0-10594" ref-type="bibr">13</xref>,<xref rid="b14-etm-0-0-10594" ref-type="bibr">14</xref>,<xref rid="b30-etm-0-0-10594" ref-type="bibr">30</xref>). Cheng <italic>et al</italic> (<xref rid="b14-etm-0-0-10594" ref-type="bibr">14</xref>) showed that upregulation of <italic>miR-424</italic> suppressed the secretion of IL-6 and IL-8 from LPS-treated alveolar epithelial cells. Guo <italic>et al</italic> (<xref rid="b30-etm-0-0-10594" ref-type="bibr">30</xref>) showed that <italic>miR-497a-5p</italic> overexpression decreased the concentration of IL-6, IL-1&#x03B2; and TNF-&#x03B1; in LPS-treated RAW264.7 cells. Li <italic>et al</italic> (<xref rid="b13-etm-0-0-10594" ref-type="bibr">13</xref>) reported that high expression levels of <italic>miR-150</italic> inhibited the secretion of IL-6, IL-1&#x03B2; and TNF-&#x03B1; from LPS-treated human pulmonary epithelial cells. In the present study, it was found that <italic>miR-30a-5p</italic> upregulation suppressed the secretion of IL-6, IL-1&#x03B2; and TNF-&#x03B1; from LPS-treated MLE-12 cells. These results suggested that <italic>miR-30a-5p</italic> may be a suppressor of the inflammatory response. Consistent with these results, <italic>miR-30a-5p</italic> inhibition has been shown to promote the release of IL-6, IL-1&#x03B2; and TNF-&#x03B1; from PC-12 cells (<xref rid="b31-etm-0-0-10594" ref-type="bibr">31</xref>). In addition, <italic>miR-30a-5p</italic> was shown to be the target of <italic>HOTAIR</italic> in the present study. Downregulation of <italic>miR-30a-5p</italic> reversed the positive effect of sh-<italic>HOTAIR</italic> on MLE-12 cell viability and the inhibitory effect of sh-<italic>HOTAIR</italic> on inflammatory factor release from MLE-12 cells. This suggested that <italic>HOTAIR</italic> knockdown alleviated the LPS-induced inflammatory response by modulating <italic>miR-30a-5p</italic>.</p>
<p>Enzymes within the phosphodiesterase (PDE) family are found in most proinflammatory and immune cells (<xref rid="b24-etm-0-0-10594" ref-type="bibr">24</xref>). As a member of the PDE family, PDE7A has been associated with the inflammatory response (<xref rid="b24-etm-0-0-10594" ref-type="bibr">24</xref>,<xref rid="b32-etm-0-0-10594 b33-etm-0-0-10594 b34-etm-0-0-10594" ref-type="bibr">32-34</xref>). Goto <italic>et al</italic> (<xref rid="b32-etm-0-0-10594" ref-type="bibr">32</xref>) reported that PDE7A downregulation ameliorated concanavalin A-induced hepatitis in mice by suppressing the concentration of IL-4 and TNF-&#x03B1;. Kadoshima-Yamaoka <italic>et al</italic> (<xref rid="b33-etm-0-0-10594" ref-type="bibr">33</xref>) showed that ASB16165, a PDE7A inhibitor, reduced cutaneous TNF-&#x03B1; concentration in 12-o-tetradecanoylphorbol-13-acetate-induced skin inflammation in mice. Yamamoto <italic>et al</italic> (<xref rid="b34-etm-0-0-10594" ref-type="bibr">34</xref>) demonstrated that YM-393059, an inhibitor of PDE7A, inhibited LPS-induced TNF-&#x03B1; production in mice. In the present study, it was found that PDE7A protein expression levels were upregulated in LPS-treated MLE-12 cells and PDE7A overexpression accelerated inflammatory factor release from the MLE-12 cells. These results suggested that PDE7A was associated with promoting the secretion of the inflammatory factors, whereas inhibiting PDE7A may be beneficial in preventing inflammation in ARDS. In addition, PDE7A overexpression reversed the positive effect of sh-<italic>HOTAIR</italic> on cell viability and the inhibitory effect of sh-<italic>HOTAIR</italic> on inflammatory factor release from the MLE-12 cells. This suggested that <italic>HOTAIR</italic> knockdown attenuated the LPS-induced inflammatory response by regulating PDE7A. At the same time, <italic>PDE7A</italic> was the target gene of <italic>miR-30a-5p</italic>. We further hypothesized that knockdown of <italic>HOTAIR</italic> ameliorated the LPS-induced inflammatory response by regulating the <italic>miR-30a-5p</italic>/<italic>PDE7A</italic> axis.</p>
<p>Taken together, the results of the current study showed that <italic>HOTAIR</italic> knockdown ameliorated the LPS-induced inflammatory response and ARDS <italic>in vivo</italic> and reduced LPS-induced inflammatory factor production by regulating the <italic>miR-30a-5p</italic>/<italic>PDE7A</italic> axis <italic>in vitro</italic>. However, there were also some limitations. First, the detailed mechanism involving <italic>HOTAIR</italic>, <italic>miR-30a-5p</italic> and PDE7A was not confirmed <italic>in vivo</italic>. Second, the detailed mechanism of this axis and the signaling pathways involved remain unclear. Further experiments will be performed to elucidate these in the future. In conclusion, these findings may contribute to the development of a new strategy for treating ARDS.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>All data generated or analyzed during this study are included in this published article.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>XM conceived and designed the present study. HW and SS performed the experiments, analyzed the data and drafted the article. XM revised the article critically for important intellectual content. XM, HW and SS confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>All experimental procedures were conducted in agreement with the principles approved by the ethical committee of Yantai Yuhuangding hospital (Yantai, China; approval no. 2019017).</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-10594"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>VJ</given-names></name><name><surname>Roy</surname><given-names>SB</given-names></name><name><surname>Mehta</surname><given-names>HJ</given-names></name><name><surname>Joo</surname><given-names>M</given-names></name><name><surname>Sadikot</surname><given-names>RT</given-names></name></person-group><article-title>Alternative and Natural therapies for acute lung injury and acute respiratory distress syndrome</article-title><source>Biomed Res Int</source><volume>2018</volume><issue>2476824</issue><year>2018</year><pub-id pub-id-type="pmid">29862257</pub-id><pub-id pub-id-type="doi">10.1155/2018/2476824</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-10594"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Esteban</surname><given-names>A</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>van Haren</surname><given-names>F</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>McAuley</surname><given-names>DF</given-names></name><etal/></person-group><article-title>Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries</article-title><source>JAMA</source><volume>315</volume><fpage>788</fpage><lpage>800</lpage><year>2016</year><pub-id pub-id-type="pmid">26903337</pub-id><pub-id pub-id-type="doi">10.1001/jama.2016.0291</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-10594"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>J</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Kacmarek</surname><given-names>RM</given-names></name></person-group><article-title>Current incidence and outcome of the acute respiratory distress syndrome</article-title><source>Curr Opin Crit Care</source><volume>22</volume><fpage>1</fpage><lpage>6</lpage><year>2016</year><pub-id pub-id-type="pmid">26645551</pub-id><pub-id pub-id-type="doi">10.1097/MCC.0000000000000266</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-10594"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>CL</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>HM</given-names></name><name><surname>Chou</surname><given-names>TC</given-names></name></person-group><article-title>Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats</article-title><source>J Ethnopharmacol</source><volume>153</volume><fpage>197</fpage><lpage>206</lpage><year>2014</year><pub-id pub-id-type="pmid">24534526</pub-id><pub-id pub-id-type="doi">10.1016/j.jep.2014.02.010</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-10594"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opitz</surname><given-names>B</given-names></name><name><surname>Van Laak</surname><given-names>V</given-names></name><name><surname>Eitel</surname><given-names>J</given-names></name><name><surname>Suttorp</surname><given-names>N</given-names></name></person-group><article-title>Innate immune recognition in infectious and noninfectious diseases of the lung</article-title><source>Am J Respir Crit Care Med</source><volume>181</volume><fpage>1294</fpage><lpage>1309</lpage><year>2010</year><pub-id pub-id-type="pmid">20167850</pub-id><pub-id pub-id-type="doi">10.1164/rccm.200909-1427SO</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-10594"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Mallampalli</surname><given-names>RK</given-names></name></person-group><article-title>The acute respiratory distress syndrome: From mechanism to translation</article-title><source>J Immunol</source><volume>194</volume><fpage>855</fpage><lpage>860</lpage><year>2015</year><pub-id pub-id-type="pmid">25596299</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1402513</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-10594"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name><name><surname>Jing</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><etal/></person-group><article-title>Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury</article-title><source>Connect Tissue Res</source><volume>59</volume><fpage>581</fpage><lpage>592</lpage><year>2018</year><pub-id pub-id-type="pmid">29649906</pub-id><pub-id pub-id-type="doi">10.1080/03008207.2018.1439480</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-10594"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Ai</surname><given-names>F</given-names></name></person-group><article-title>Long non-coding RNA THRIL predicts increased acute respiratory distress syndrome risk and positively correlates with disease severity, inflammation, and mortality in sepsis patients</article-title><source>J Clin Lab Anal</source><volume>33</volume><issue>e22882</issue><year>2019</year><pub-id pub-id-type="pmid">31257645</pub-id><pub-id pub-id-type="doi">10.1002/jcla.22882</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-10594"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name></person-group><article-title>Depression of lncRNA NEAT1 Antagonizes LPS-evoked acute injury and inflammatory response in alveolar epithelial cells via HMGB1-RAGE signaling</article-title><source>Mediators Inflamm</source><volume>2020</volume><issue>8019467</issue><year>2020</year><pub-id pub-id-type="pmid">32089649</pub-id><pub-id pub-id-type="doi">10.1155/2020/8019467</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-10594"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Niu</surname><given-names>S</given-names></name></person-group><comment>WITHDRAWN: Long non-coding RNA HOTAIR promotes LPS-induced inflammatory injury by down-regulation of microRNA-124 in murine chondrogenic ATDC5 cells. Life Sci: July 20, 2018 (Epub ahead of print).</comment></element-citation></ref>
<ref id="b11-etm-0-0-10594"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obaid</surname><given-names>M</given-names></name><name><surname>Udden</surname><given-names>SMN</given-names></name><name><surname>Deb</surname><given-names>P</given-names></name><name><surname>Shihabeddin</surname><given-names>N</given-names></name><name><surname>Zaki</surname><given-names>MH</given-names></name><name><surname>Mandal</surname><given-names>SS</given-names></name></person-group><article-title>LncRNA HOTAIR regulates lipopolysaccharide-induced cytokine expression and inflammatory response in macrophages</article-title><source>Sci Rep</source><volume>8</volume><issue>15670</issue><year>2018</year><pub-id pub-id-type="pmid">30353135</pub-id><pub-id pub-id-type="doi">10.1038/s41598-018-33722-2</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-10594"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>LncRNA-HOTAIR promotes TNF-&#x03B1; production in cardiomyocytes of LPS-induced sepsis mice by activating NF-&#x03BA;B pathway</article-title><source>Biochem Biophys Res Commun</source><volume>471</volume><fpage>240</fpage><lpage>246</lpage><year>2016</year><pub-id pub-id-type="pmid">26806307</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.01.117</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-10594"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3</article-title><source>Int Immunopharmacol</source><volume>75</volume><issue>105794</issue><year>2019</year><pub-id pub-id-type="pmid">31398659</pub-id><pub-id pub-id-type="doi">10.1016/j.intimp.2019.105794</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-10594"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name></person-group><article-title>MiR-424 overexpression protects alveolar epithelial cells from LPS-induced apoptosis and inflammation by targeting FGF2 via the NF-&#x03BA;B pathway</article-title><source>Life Sci</source><volume>242</volume><issue>117213</issue><year>2020</year><pub-id pub-id-type="pmid">31881228</pub-id><pub-id pub-id-type="doi">10.1016/j.lfs.2019.117213</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-10594"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name></person-group><article-title>miR-146b overexpression ameliorates lipopolysaccharide-induced acute lung injury in vivo and in vitro</article-title><source>J Cell Biochem</source><volume>120</volume><fpage>2929</fpage><lpage>2939</lpage><year>2019</year><pub-id pub-id-type="pmid">30500983</pub-id><pub-id pub-id-type="doi">10.1002/jcb.26846</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-10594"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name></person-group><article-title>The functional mechanisms of miR-30b-5p in acute lung injury in children</article-title><source>Med Sci Monit</source><volume>25</volume><fpage>40</fpage><lpage>51</lpage><year>2019</year><pub-id pub-id-type="pmid">30600796</pub-id><pub-id pub-id-type="doi">10.12659/MSM.911398</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-10594"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ai</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1</article-title><source>Biol Res</source><volume>53</volume><issue>18</issue><year>2020</year><pub-id pub-id-type="pmid">32349783</pub-id><pub-id pub-id-type="doi">10.1186/s40659-020-00286-3</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-10594"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name></person-group><article-title>LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1</article-title><source>Gastric Cancer</source><volume>23</volume><fpage>1018</fpage><lpage>1032</lpage><year>2020</year><pub-id pub-id-type="pmid">32583079</pub-id><pub-id pub-id-type="doi">10.1007/s10120-020-01091-3</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-10594"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Cui</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name></person-group><article-title>LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p</article-title><source>Thorac Cancer</source><volume>11</volume><fpage>1801</fpage><lpage>1816</lpage><year>2020</year><pub-id pub-id-type="pmid">32374522</pub-id><pub-id pub-id-type="doi">10.1111/1759-7714.13450</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-10594"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-601</article-title><source>Cancer Cell Int</source><volume>20</volume><issue>320</issue><year>2020</year><pub-id pub-id-type="pmid">32694942</pub-id><pub-id pub-id-type="doi">10.1186/s12935-020-01410-9</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-10594"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Bi</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Shu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Exosomal HOTAIR promotes proliferation, migration and invasion of lung cancer by sponging miR-203</article-title><source>Sci China Life Sci</source><volume>63</volume><fpage>1265</fpage><lpage>1268</lpage><year>2020</year><pub-id pub-id-type="pmid">31925755</pub-id><pub-id pub-id-type="doi">10.1007/s11427-019-1579-x</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-10594"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="pmid">11846609</pub-id><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-10594"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>T</given-names></name></person-group><article-title>Prevention of LPS-induced acute lung injury in mice by progranulin</article-title><source>Mediators Inflamm</source><volume>2012</volume><issue>540794</issue><year>2012</year><pub-id pub-id-type="pmid">22969170</pub-id><pub-id pub-id-type="doi">10.1155/2012/540794</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-10594"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SJ</given-names></name><name><surname>Brookes-Fazakerley</surname><given-names>S</given-names></name><name><surname>Donnelly</surname><given-names>LE</given-names></name><name><surname>Barnes</surname><given-names>PJ</given-names></name><name><surname>Barnette</surname><given-names>MS</given-names></name><name><surname>Giembycz</surname><given-names>MA</given-names></name></person-group><article-title>Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>284</volume><fpage>L279</fpage><lpage>L289</lpage><year>2003</year><pub-id pub-id-type="pmid">12388353</pub-id><pub-id pub-id-type="doi">10.1152/ajplung.00170.2002</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-10594"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrucci</surname><given-names>N</given-names></name><name><surname>De Feo</surname><given-names>C</given-names></name></person-group><article-title>Lung protective ventilation strategy for the acute respiratory distress syndrome</article-title><source>Cochrane Database Syst Rev</source><volume>2013</volume><issue>CD003844</issue><year>2007</year><pub-id pub-id-type="pmid">23450544</pub-id><pub-id pub-id-type="doi">10.1002/14651858.CD003844.pub4</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-10594"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Qiao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis</article-title><source>J Cell Mol Med</source><volume>20</volume><fpage>1234</fpage><lpage>1246</lpage><year>2016</year><pub-id pub-id-type="pmid">26824344</pub-id><pub-id pub-id-type="doi">10.1111/jcmm.12783</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-10594"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Huangfu</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis</article-title><source>Cell Death Dis</source><volume>5</volume><issue>e1238</issue><year>2014</year><pub-id pub-id-type="pmid">24853416</pub-id><pub-id pub-id-type="doi">10.1038/cddis.2014.207</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-10594"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunkel</surname><given-names>B</given-names></name></person-group><article-title>Acute lung injury and acute respiratory distress syndrome in foals</article-title><source>Equine Vet J</source><volume>5</volume><fpage>127</fpage><lpage>133</lpage><year>2006</year></element-citation></ref>
<ref id="b29-etm-0-0-10594"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Lou</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wei</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name></person-group><article-title>Kcnq1ot1/miR-381-3p/ETS2 axis regulates inflammation in mouse models of acute respiratory distress syndrome</article-title><source>Mol Ther Nucleic Acids</source><volume>19</volume><fpage>179</fpage><lpage>189</lpage><year>2020</year><pub-id pub-id-type="pmid">31841990</pub-id><pub-id pub-id-type="doi">10.1016/j.omtn.2019.10.036</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-10594"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Shaukat</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>G</given-names></name></person-group><article-title>miR-497a-5p attenuates lipopolysaccharide-induced inflammatory injury by targeting IRAK2</article-title><source>J Cell Physiol</source><volume>234</volume><fpage>22874</fpage><lpage>22883</lpage><year>2019</year><pub-id pub-id-type="pmid">31148190</pub-id><pub-id pub-id-type="doi">10.1002/jcp.28850</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-10594"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Jiao</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>YE</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><article-title>Suppression of LINC00707 alleviates lipopolysaccharide-induced inflammation and apoptosis in PC-12 cells by regulated miR-30a-5p/Neurod 1</article-title><source>Biosci Biotechnol Biochem</source><volume>83</volume><fpage>2049</fpage><lpage>2056</lpage><year>2019</year><pub-id pub-id-type="pmid">31272297</pub-id><pub-id pub-id-type="doi">10.1080/09168451.2019.1637245</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-10594"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Murakawa</surname><given-names>M</given-names></name><name><surname>Kadoshima-Yamaoka</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Murafuji</surname><given-names>H</given-names></name><name><surname>Nagahira</surname><given-names>A</given-names></name><name><surname>Kanki</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Nagahira</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice</article-title><source>Int Immunopharmacol</source><volume>9</volume><fpage>1347</fpage><lpage>1351</lpage><year>2009</year><pub-id pub-id-type="pmid">19671449</pub-id><pub-id pub-id-type="doi">10.1016/j.intimp.2009.08.002</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-10594"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadoshima-Yamaoka</surname><given-names>K</given-names></name><name><surname>Goto</surname><given-names>M</given-names></name><name><surname>Murakawa</surname><given-names>M</given-names></name><name><surname>Yoshioka</surname><given-names>R</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Murafuji</surname><given-names>H</given-names></name><name><surname>Kanki</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Nagahira</surname><given-names>K</given-names></name><etal/></person-group><article-title>ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-alpha level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice</article-title><source>Eur J Pharmacol</source><volume>613</volume><fpage>163</fpage><lpage>166</lpage><year>2009</year><pub-id pub-id-type="pmid">19379723</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.04.014</pub-id></element-citation></ref>
<ref id="b34-etm-0-0-10594"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Sugahara</surname><given-names>S</given-names></name><name><surname>Naito</surname><given-names>R</given-names></name><name><surname>Ichikawa</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name></person-group><article-title>The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo</article-title><source>Eur J Pharmacol</source><volume>541</volume><fpage>106</fpage><lpage>114</lpage><year>2006</year><pub-id pub-id-type="pmid">16780833</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.05.007</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-10594" position="float">
<label>Figure 1</label>
<caption><p>lncRNA HOTAIR knockdown decreases the concentration of inflammatory factors in LPS-induced MLE-12 cells. (A) The mRNA expression level of lncRNA HOTAIR in the MLE-12 cells was detected using RT-qPCR. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. control. (B) The mRNA expression of lncRNA HOTAIR following transfection with sh-HOTAIR/NC into the MLE-12 cells was detected using RT-qPCR. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. sh-NC. (C) The viability of the MLE-12 cells was measured using a MTT assay. The concentration of (D) IL-6, (E) IL-1&#x03B2; and (F) TNF-&#x03B1; following transfection with sh-HOTAIR/NC into the MLE-12 cells was measured using ELISA. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. control. <sup>&#x0023;&#x0023;</sup>P&#x003C;0.01 vs. sh-NC. NC, negative control; lnc, long non-coding; LPS, lipopolysaccharide; TNF, tumor necrosis factor; RT-qPCR, reverse transcription-quantitative PCR; sh, short hairpin.</p></caption>
<graphic xlink:href="etm-22-04-10594-g00.tif" />
</fig>
<fig id="f2-etm-0-0-10594" position="float">
<label>Figure 2</label>
<caption><p>miR-30a-5p is the direct target of lncRNA HOTAIR. (A) The predicted complementary binding site between lncRNA HOTAIR and miR-30a-5p. (B) The mRNA expression level of miR-30a-5p following transfection with sh-HOTAIR/NC into the MLE-12 cells was detected using reverse transcription-quantitative PCR. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. sh-NC. (C) The luciferase activity in the MLE-12 cells co-transfected with pGL3-HOTAIR WT/pGL3-HOTAIR MUT and miR-30a-5p mimics/NC was determined using a dual luciferase reporter assay. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. miR-NC. NC, negative control; lnc, long non-coding; miR, microRNA, sh, short hairpin; WT, wild-type; MUT, mutant.</p></caption>
<graphic xlink:href="etm-22-04-10594-g01.tif" />
</fig>
<fig id="f3-etm-0-0-10594" position="float">
<label>Figure 3</label>
<caption><p>Overexpression of miR-30a-5p reduces the concentration of the inflammatory factors in LPS-induced MLE-12 cells. (A) The mRNA expression level of miR-30a-5p in the MLE-12 cells was detected using RT-qPCR. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. control. (B) The mRNA expression level of miR-30a-5p following transfection with miR-30a-5p mimics/inhibitor/NC into the MLE-12 cells was detected using RT-qPCR. (C) The viability of the MLE-12 cells was measured using a MTT assay. The concentration of (D) IL-6, (E) IL-1&#x03B2; and (F) TNF-&#x03B1; following transfection with miR-30a-5p mimics/NC into the MLE-12 cells was measured using ELISA. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. miR-NC. <sup>&#x0023;&#x0023;</sup>P&#x003C;0.01 vs. inhibitor NC. NC, negative control; miR, microRNA; LPS, lipopolysaccharide; TNF, tumor necrosis factor; RT-qPCR, reverse transcription-quantitative PCR.</p></caption>
<graphic xlink:href="etm-22-04-10594-g02.tif" />
</fig>
<fig id="f4-etm-0-0-10594" position="float">
<label>Figure 4</label>
<caption><p>miR-30a-5p targets PDE7A. (A) The predicted complementary binding site between miR-30a-5p and PDE7A. (B) The protein expression level of PDE7A following transfection with miR-30a-5p mimics/NC into the MLE-12 cells was determined using western blot analysis. (C) The luciferase activity in the MLE-12 cells co-transfected with pGL3-PDE7A WT/pGL3-PDE7A MUT and miR-30a-5p mimics/NC was determined using a dual luciferase reporter assay. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. miR-NC. NC, negative control; miR, microRNA; WT, wild-type; MUT, mutant.</p></caption>
<graphic xlink:href="etm-22-04-10594-g03.tif" />
</fig>
<fig id="f5-etm-0-0-10594" position="float">
<label>Figure 5</label>
<caption><p>lncRNA HOTAIR knockdown decreases the concentration of the inflammatory factors in LPS-induced MLE-12 cells by regulating the miR-30a-5p/PDE7A axis. (A) The protein expression level of PDE7A in the MLE-12 cells was determined using a western blot assay. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. control. (B) The protein expression level of PDE7A following transfection with pcDNA-PDE7A/NC into the MLE-12 cells was determined using western blot analysis. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. pcDNA-NC. (C) The protein expression level of PDE7A following transfection with sh-HOTAIR + miR-30a-5p inhibitor/sh-HOTAIR/NC into the MLE-12 cells was determined using western blot analysis. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. sh-NC. <sup>&#x0023;&#x0023;</sup>P&#x003C;0.01 vs. sh-HOTAIR. (D) The viability of the MLE-12 cells was measured using a MTT assay. The level of (E) IL-6, (F) IL-1&#x03B2; and (G) TNF-&#x03B1; following transfection with sh-HOTAIR + miR-30a-5p inhibitor/sh-HOTAIR + pcDNA-PDE7A/sh-HOTAIR/NC into the MLE-12 cells was measured using ELISA. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. sh-NC. <sup>&#x0023;&#x0023;</sup>P&#x003C;0.01 vs. sh-HOTAIR. NC, negative control; miR, microRNA; LPS, lipopolysaccharide; TNF, tumor necrosis factor; sh, short hairpin.</p></caption>
<graphic xlink:href="etm-22-04-10594-g04.tif" />
</fig>
<fig id="f6-etm-0-0-10594" position="float">
<label>Figure 6</label>
<caption><p>lncRNA HOTAIR knockdown attenuates LPS-induced ARDS and ARDS-related inflammatory response <italic>in vivo</italic>. The mRNA expression level of (A) HOTAIR, (B) miR-30a-5p and (C) PDE7A in the lung tissues of mice was detected using reverse transcription-quantitative PCR. (D) Histopathological change and injury score were detected using H&#x0026;E staining. Magnification, x200. (E) Lung wet/dry weight ratio, (F) PaO<sub>2</sub> and (G) PaCO<sub>2</sub> was measured using an automatic blood gas analyzer. The concentration of (H) IL-6, (I) IL-1&#x03B2; and (J) TNF-&#x03B1; in BALF of mice was measured using ELISA. <sup>&#x002A;&#x002A;</sup>P&#x003C;0.01 vs. sham. <sup>&#x0023;&#x0023;</sup>P&#x003C;0.01 vs. ARDS. Pa, partial pressure; TNF, tumor necrosis factor; miR, microRNA; NC, negative control; sh, short hairpin; ARDS, acute respiratory distress syndrome.</p></caption>
<graphic xlink:href="etm-22-04-10594-g05.tif" />
</fig>
</floats-group>
</article>
